A hamster model for Marburg virus infection accurately recapitulates Marburg hemorrhagic fever

Citations Over TimeTop 10% of 2016 papers

Abstract

Marburg virus (MARV), a close relative of Ebola virus, is the causative agent of a severe human disease known as Marburg hemorrhagic fever (MHF). No licensed vaccine or therapeutic exists to treat MHF, and MARV is therefore classified as a Tier 1 select agent and a category A bioterrorism agent. In order to develop countermeasures against this severe disease, animal models that accurately recapitulate human disease are required. Here we describe the development of a novel, uniformly lethal Syrian golden hamster model of MHF using a hamster-adapted MARV variant Angola. Remarkably, this model displayed almost all of the clinical features of MHF seen in humans and non-human primates, including coagulation abnormalities, hemorrhagic manifestations, petechial rash, and a severely dysregulated immune response. This MHF hamster model represents a powerful tool for further dissecting MARV pathogenesis and accelerating the development of effective medical countermeasures against human MHF.

Related Papers

• → Development and optimization of biologically contained Marburg virus for high-throughput antiviral screening(2022)8 cited
• → Enteropathogenicity of Escherichia coli isolated from hamsters (Mesocricetus auratus) with hamster enteritis(1978)11 cited
• → Female protein, amyloidosis, and hormonal carcinogenesis in Turkish hamster: differences from Syrian hamster(1997)9 cited
• → Effect of Hamster Pregnancy on Female Protein, a Homolog of Serum Amyloid P Component(1999)1 cited
• → Effect of Hamster Pregnancy on Female Protein, a Homolog of Serum Amyloid P Component(1999)1 cited